El documento presenta una introducción a un tema relacionado con el conocimiento del mundo a través de la exploración de lo desconocido y el universo que nos rodea, ya que este es el momento para hacerlo.
This document discusses liver cancer, including its causes, symptoms, diagnosis, and treatment options. It defines primary and secondary liver cancer and notes various causes. Diagnosis involves physical exams, blood tests, and imaging studies like ultrasound, CT scans, and MRI. Treatment options reviewed are surgery, chemotherapy, radiofrequency ablation (RFA), and TheraSphere. TheraSphere involves inserting radioactive glass beads into the hepatic artery and is presented as a new, targeted treatment option with fewer side effects than other therapies. A case study is presented demonstrating the treatment process for a patient receiving TheraSphere.
This slide deck has been created for clinician use in creating presentations detailing Colorectal Cancer Liver Metastases, the Selective Internal Radiation Therapy (SIRT) procedure available to treat this condition, supported by the clinical data that supports this treatment and and ongoing RCT trials to further document the success of this treatment. This information maybe used in its entirety or in sections, according to the material being presented and the audience to which it will be used. The sections included in this slide deck are as follows:
Colorectal Cancer Liver Metastases (mCRC)
Overview Selective Internal Radiation Therapy (SIRT)
Overview SIR-Spheres(r) microspheres
Clinical Data in mCRC Ongoing Level 1 RCT for mCRC in the liver
Este documento presenta una propuesta para desarrollar una clasificación LI-RADS ecográfica (LI-RADS CVA) para clasificar lesiones hepáticas, similar a la clasificación LI-RADS utilizada en TC y RM pero adaptada a la ecografía. Explica las cinco categorías propuestas para la LI-RADS CVA (definitivamente benigna, probablemente benigna, probabilidad intermedia de hepatocarcinoma, alta sospecha de malignidad y definitivamente hepatocarcinoma) y define las características ecográficas y de contraste
management of hepatocellular carcinoma Sujay Susikar
The document provides information on hepatocellular carcinoma (HCC) including its epidemiology, etiology, risk factors, staging systems, surveillance, diagnosis, treatment options and surgical approaches. It discusses that HCC is the 5th most common cancer worldwide with the major risk factors being hepatitis B, cirrhosis, and alcohol. Staging systems covered include TNM, Okuda, CLIP and BCLC. Treatment options depend on tumor stage and liver function/reserve and may include resection, ablation, transarterial chemoembolization or transplantation. Surgical approaches to resection involve either anatomical or atypical resections.
I have uploaded the presentation on Yttrium 90 & its application in treatment of Liver Cancer. Presentation elaborates on characteristics of Y-90, how treatment is planned, workup done & aspects on radiation safety & post treatment care. I would be glad to answer queries on this new emerging exciting area of treating Inoperable Liver Cancers.
Abdominal imaging treatment of inoperable hcc p kwokJFIM
This document discusses the treatment of inoperable hepatocellular carcinoma (HCC) in Hong Kong. It outlines that transarterial chemoembolization (TACE) is the most common treatment used, involving injection of an emulsion of lipiodol and chemotherapy drugs into the hepatic artery. TACE is performed every 2-3 months to palliatively treat inoperable HCC tumors. The document also discusses other local ablation techniques used such as radiofrequency ablation when tumors are unresectable but not truly inoperable. It notes that guidelines for treatment of HCC continue to evolve as new evidence and techniques emerge.
This document provides an overview of hepatocellular carcinoma (HCC). It discusses the anatomy, epidemiology, screening, diagnosis, staging and management of HCC. HCC is commonly caused by viral hepatitis and cirrhosis. Diagnosis involves imaging such as ultrasound, CT or MRI showing characteristic arterial enhancement and venous washout. Staging systems include AJCC, Okuda, CLIP and BCLC which incorporate tumor burden, liver function and performance status. Management options include surgical resection, liver transplantation, ablation and arterially directed therapies like TACE.
The document discusses liver cancer, including its causes, risk factors, symptoms, diagnosis, and treatment. It states that liver cancer is difficult to diagnose and treat, as the liver is an important organ involved in many bodily functions. The cancer often develops due to conditions like hepatitis or cirrhosis that damage the liver over time. Symptoms can include abdominal swelling and pain, and diagnosis involves medical imaging and biopsy. Treatment options depend on cancer stage and liver health, and may include surgery, chemotherapy, radiation, or other approaches. Maintaining a healthy lifestyle is important to prevent risk factors and protect the liver.
This document discusses liver cancer, including its causes, symptoms, diagnosis, and treatment options. It defines primary and secondary liver cancer and notes various causes. Diagnosis involves physical exams, blood tests, and imaging studies like ultrasound, CT scans, and MRI. Treatment options reviewed are surgery, chemotherapy, radiofrequency ablation (RFA), and TheraSphere. TheraSphere involves inserting radioactive glass beads into the hepatic artery and is presented as a new, targeted treatment option with fewer side effects than other therapies. A case study is presented demonstrating the treatment process for a patient receiving TheraSphere.
This slide deck has been created for clinician use in creating presentations detailing Colorectal Cancer Liver Metastases, the Selective Internal Radiation Therapy (SIRT) procedure available to treat this condition, supported by the clinical data that supports this treatment and and ongoing RCT trials to further document the success of this treatment. This information maybe used in its entirety or in sections, according to the material being presented and the audience to which it will be used. The sections included in this slide deck are as follows:
Colorectal Cancer Liver Metastases (mCRC)
Overview Selective Internal Radiation Therapy (SIRT)
Overview SIR-Spheres(r) microspheres
Clinical Data in mCRC Ongoing Level 1 RCT for mCRC in the liver
Este documento presenta una propuesta para desarrollar una clasificación LI-RADS ecográfica (LI-RADS CVA) para clasificar lesiones hepáticas, similar a la clasificación LI-RADS utilizada en TC y RM pero adaptada a la ecografía. Explica las cinco categorías propuestas para la LI-RADS CVA (definitivamente benigna, probablemente benigna, probabilidad intermedia de hepatocarcinoma, alta sospecha de malignidad y definitivamente hepatocarcinoma) y define las características ecográficas y de contraste
management of hepatocellular carcinoma Sujay Susikar
The document provides information on hepatocellular carcinoma (HCC) including its epidemiology, etiology, risk factors, staging systems, surveillance, diagnosis, treatment options and surgical approaches. It discusses that HCC is the 5th most common cancer worldwide with the major risk factors being hepatitis B, cirrhosis, and alcohol. Staging systems covered include TNM, Okuda, CLIP and BCLC. Treatment options depend on tumor stage and liver function/reserve and may include resection, ablation, transarterial chemoembolization or transplantation. Surgical approaches to resection involve either anatomical or atypical resections.
I have uploaded the presentation on Yttrium 90 & its application in treatment of Liver Cancer. Presentation elaborates on characteristics of Y-90, how treatment is planned, workup done & aspects on radiation safety & post treatment care. I would be glad to answer queries on this new emerging exciting area of treating Inoperable Liver Cancers.
Abdominal imaging treatment of inoperable hcc p kwokJFIM
This document discusses the treatment of inoperable hepatocellular carcinoma (HCC) in Hong Kong. It outlines that transarterial chemoembolization (TACE) is the most common treatment used, involving injection of an emulsion of lipiodol and chemotherapy drugs into the hepatic artery. TACE is performed every 2-3 months to palliatively treat inoperable HCC tumors. The document also discusses other local ablation techniques used such as radiofrequency ablation when tumors are unresectable but not truly inoperable. It notes that guidelines for treatment of HCC continue to evolve as new evidence and techniques emerge.
This document provides an overview of hepatocellular carcinoma (HCC). It discusses the anatomy, epidemiology, screening, diagnosis, staging and management of HCC. HCC is commonly caused by viral hepatitis and cirrhosis. Diagnosis involves imaging such as ultrasound, CT or MRI showing characteristic arterial enhancement and venous washout. Staging systems include AJCC, Okuda, CLIP and BCLC which incorporate tumor burden, liver function and performance status. Management options include surgical resection, liver transplantation, ablation and arterially directed therapies like TACE.
The document discusses liver cancer, including its causes, risk factors, symptoms, diagnosis, and treatment. It states that liver cancer is difficult to diagnose and treat, as the liver is an important organ involved in many bodily functions. The cancer often develops due to conditions like hepatitis or cirrhosis that damage the liver over time. Symptoms can include abdominal swelling and pain, and diagnosis involves medical imaging and biopsy. Treatment options depend on cancer stage and liver health, and may include surgery, chemotherapy, radiation, or other approaches. Maintaining a healthy lifestyle is important to prevent risk factors and protect the liver.
Hepatocellular carcinoma is a primary cancer of the liver that is commonly associated with cirrhosis and hepatitis. Common causes include cirrhosis from various sources, chronic hepatitis B or C infection, and alcohol consumption. Symptoms can include abdominal pain, weight loss, jaundice, and nausea. Diagnosis involves imaging such as CT or MRI scans of the liver along with blood tests. Treatment options depend on factors like tumor size and liver function, and may include resection, transplantation, ablation, embolization, or chemotherapy. Prognosis can be assessed using scoring systems like the Child-Pugh score.
This document discusses hepatocellular carcinoma (HCC). It outlines the main risk factors for HCC as hepatitis B and C, alcohol, aflatoxin, and certain genetic conditions. It notes that 60-80% of HCC cases occur in patients with cirrhosis. The document discusses screening and diagnosis of HCC using AFP levels and imaging modalities. It covers staging of HCC and describes treatment options including surgery, ablation, embolization, and transplantation.
This document discusses the current approach for diagnostic imaging of small hepatocellular carcinoma (HCC) in patients with liver cirrhosis using gadoxetic acid (Primovist) enhanced magnetic resonance imaging (MRI) and diffusion weighted imaging (DWI). It summarizes that the combined use of Primovist MRI and DWI provides high diagnostic accuracy and sensitivity, particularly for detecting HCC lesions smaller than 2cm. This approach can image the step-wise progression of hepatocarcinogenesis by assessing vascularity, hepatocyte function, and cell density. The summary highlights that while Primovist MRI alone has high sensitivity, it has compromised specificity, but combining it with DWI increases specificity by differentiating HCC from
Hepatocellular carcinoma is the most common primary liver tumor. Risk factors include hepatitis B and C infections, alcohol use, and exposure to aflatoxins. It typically presents with nonspecific symptoms in patients with underlying liver disease or cirrhosis. Diagnosis involves blood tests like alpha-fetoprotein along with imaging modalities. Treatment options depend on tumor stage and liver function, and may include surgical resection, liver transplantation, ablation, or chemoembolization. Prevention focuses on hepatitis B vaccination and screening high-risk groups to detect cancer early.
Hepatocellular carcinoma is one of the most common malignancies worldwide. Its incidence varies significantly between regions, from low rates in the United States and Africa to very high rates in parts of Asia. Major risk factors include chronic hepatitis B and C infections. Clinical features can include abdominal pain, weight loss, jaundice, and hepatomegaly. Diagnosis involves blood tests, ultrasound, CT scan, MRI and sometimes liver biopsy. High-risk groups are screened regularly through alpha-fetoprotein testing and ultrasound. Treatment options depend on the stage but may include surgical resection, ablation, chemotherapy, and transplantation.
1) Hepatocellular carcinoma (HCC) is the 6th most common cancer worldwide and the 3rd leading cause of cancer death. The incidence of HCC in the US has doubled from 1985-1998.
2) Risk factors for HCC include hepatitis B and C infection, alcohol use, non-alcoholic fatty liver disease, and hereditary conditions. Cirrhosis of the liver greatly increases the risk of developing HCC.
3) Screening high-risk patients such as those with cirrhosis every 6-12 months with ultrasound and alpha-fetoprotein blood tests can help detect HCC at an early stage when more treatment options are available.
Este documento descreve um projeto escolar sobre doenças cardiovasculares realizado por um grupo de alunos. O projeto teve como objetivos divulgar informações sobre as doenças cardiovasculares e sensibilizar a população sobre os fatores de risco. Ao longo do ano letivo, o grupo realizou várias atividades como inquéritos, visitas, palestras e um dia de atividades físicas. No final, concluíram que conseguiram cumprir os objetivos propostos apesar de alguns obstáculos.
O documento lista as áreas necessárias para um centro de saúde e bem-estar, incluindo uma sala de receção, consultórios, sala de grupo, escritórios, ginásio, balneários, casa de banho e piscina.
Um questionário de 6 perguntas foi aplicado após uma palestra sobre os riscos do tabagismo para doenças cardiovasculares. As perguntas avaliaram se o tema foi interessante, se o tabagismo é agora visto como maior fator de risco, se o participante fuma e como a palestra impactou seu hábito, se a palestrante foi esclarecedora e se o participante tem interesse em seguir as atividades do grupo. A escala final avalia de 0 a 5 a conveniência da palestra.
Um documento contendo uma pesquisa após uma palestra sobre os riscos do tabagismo para doenças cardiovasculares. A pesquisa continha perguntas sobre se o tema foi interessante, se o tabagismo é agora visto como maior fator de risco, se o entrevistado fuma e o impacto da palestra nesse hábito, se a palestrante foi esclarecedora e se o entrevistado tem interesse em seguir as atividades do grupo.
O documento apresenta os resultados de um inquérito realizado a alunos de 17, 18 e 19 anos sobre doenças cardiovasculares. Os resultados mostram que a maioria dos alunos encara as doenças cardiovasculares como um fator de risco importante e identifica hábitos alimentares saudáveis e exercício físico como formas de prevenção. No entanto, muitos alunos raramente realizam exames médicos de prevenção.
O documento descreve as atividades realizadas durante um "Dia D", incluindo jogos tradicionais como o jogo do saco e do ovo, torneios de jogos como a macaca e latas, e resultados de um inquérito sobre preferências de esportes e opinião sobre a organização do evento.
O documento descreve um projeto de um grupo de estudantes sobre doenças cardiovasculares. O objetivo do projeto é divulgar informações sobre as principais causas de morte em Portugal, sensibilizar a população sobre hábitos saudáveis e realizar atividades como visitas, palestras, rastreios de saúde e eventos esportivos. O documento detalha o cronograma das atividades, os recursos necessários, os contatos e a divisão de tarefas entre os membros do grupo.
Hepatocellular carcinoma is a primary cancer of the liver that is commonly associated with cirrhosis and hepatitis. Common causes include cirrhosis from various sources, chronic hepatitis B or C infection, and alcohol consumption. Symptoms can include abdominal pain, weight loss, jaundice, and nausea. Diagnosis involves imaging such as CT or MRI scans of the liver along with blood tests. Treatment options depend on factors like tumor size and liver function, and may include resection, transplantation, ablation, embolization, or chemotherapy. Prognosis can be assessed using scoring systems like the Child-Pugh score.
This document discusses hepatocellular carcinoma (HCC). It outlines the main risk factors for HCC as hepatitis B and C, alcohol, aflatoxin, and certain genetic conditions. It notes that 60-80% of HCC cases occur in patients with cirrhosis. The document discusses screening and diagnosis of HCC using AFP levels and imaging modalities. It covers staging of HCC and describes treatment options including surgery, ablation, embolization, and transplantation.
This document discusses the current approach for diagnostic imaging of small hepatocellular carcinoma (HCC) in patients with liver cirrhosis using gadoxetic acid (Primovist) enhanced magnetic resonance imaging (MRI) and diffusion weighted imaging (DWI). It summarizes that the combined use of Primovist MRI and DWI provides high diagnostic accuracy and sensitivity, particularly for detecting HCC lesions smaller than 2cm. This approach can image the step-wise progression of hepatocarcinogenesis by assessing vascularity, hepatocyte function, and cell density. The summary highlights that while Primovist MRI alone has high sensitivity, it has compromised specificity, but combining it with DWI increases specificity by differentiating HCC from
Hepatocellular carcinoma is the most common primary liver tumor. Risk factors include hepatitis B and C infections, alcohol use, and exposure to aflatoxins. It typically presents with nonspecific symptoms in patients with underlying liver disease or cirrhosis. Diagnosis involves blood tests like alpha-fetoprotein along with imaging modalities. Treatment options depend on tumor stage and liver function, and may include surgical resection, liver transplantation, ablation, or chemoembolization. Prevention focuses on hepatitis B vaccination and screening high-risk groups to detect cancer early.
Hepatocellular carcinoma is one of the most common malignancies worldwide. Its incidence varies significantly between regions, from low rates in the United States and Africa to very high rates in parts of Asia. Major risk factors include chronic hepatitis B and C infections. Clinical features can include abdominal pain, weight loss, jaundice, and hepatomegaly. Diagnosis involves blood tests, ultrasound, CT scan, MRI and sometimes liver biopsy. High-risk groups are screened regularly through alpha-fetoprotein testing and ultrasound. Treatment options depend on the stage but may include surgical resection, ablation, chemotherapy, and transplantation.
1) Hepatocellular carcinoma (HCC) is the 6th most common cancer worldwide and the 3rd leading cause of cancer death. The incidence of HCC in the US has doubled from 1985-1998.
2) Risk factors for HCC include hepatitis B and C infection, alcohol use, non-alcoholic fatty liver disease, and hereditary conditions. Cirrhosis of the liver greatly increases the risk of developing HCC.
3) Screening high-risk patients such as those with cirrhosis every 6-12 months with ultrasound and alpha-fetoprotein blood tests can help detect HCC at an early stage when more treatment options are available.
Este documento descreve um projeto escolar sobre doenças cardiovasculares realizado por um grupo de alunos. O projeto teve como objetivos divulgar informações sobre as doenças cardiovasculares e sensibilizar a população sobre os fatores de risco. Ao longo do ano letivo, o grupo realizou várias atividades como inquéritos, visitas, palestras e um dia de atividades físicas. No final, concluíram que conseguiram cumprir os objetivos propostos apesar de alguns obstáculos.
O documento lista as áreas necessárias para um centro de saúde e bem-estar, incluindo uma sala de receção, consultórios, sala de grupo, escritórios, ginásio, balneários, casa de banho e piscina.
Um questionário de 6 perguntas foi aplicado após uma palestra sobre os riscos do tabagismo para doenças cardiovasculares. As perguntas avaliaram se o tema foi interessante, se o tabagismo é agora visto como maior fator de risco, se o participante fuma e como a palestra impactou seu hábito, se a palestrante foi esclarecedora e se o participante tem interesse em seguir as atividades do grupo. A escala final avalia de 0 a 5 a conveniência da palestra.
Um documento contendo uma pesquisa após uma palestra sobre os riscos do tabagismo para doenças cardiovasculares. A pesquisa continha perguntas sobre se o tema foi interessante, se o tabagismo é agora visto como maior fator de risco, se o entrevistado fuma e o impacto da palestra nesse hábito, se a palestrante foi esclarecedora e se o entrevistado tem interesse em seguir as atividades do grupo.
O documento apresenta os resultados de um inquérito realizado a alunos de 17, 18 e 19 anos sobre doenças cardiovasculares. Os resultados mostram que a maioria dos alunos encara as doenças cardiovasculares como um fator de risco importante e identifica hábitos alimentares saudáveis e exercício físico como formas de prevenção. No entanto, muitos alunos raramente realizam exames médicos de prevenção.
O documento descreve as atividades realizadas durante um "Dia D", incluindo jogos tradicionais como o jogo do saco e do ovo, torneios de jogos como a macaca e latas, e resultados de um inquérito sobre preferências de esportes e opinião sobre a organização do evento.
O documento descreve um projeto de um grupo de estudantes sobre doenças cardiovasculares. O objetivo do projeto é divulgar informações sobre as principais causas de morte em Portugal, sensibilizar a população sobre hábitos saudáveis e realizar atividades como visitas, palestras, rastreios de saúde e eventos esportivos. O documento detalha o cronograma das atividades, os recursos necessários, os contatos e a divisão de tarefas entre os membros do grupo.